BHVN Biohaven Ltd.
NYSE · SEC CIK 1935979 · EDGAR
- Bought, last 12 months
- $33.14M 4 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 115 since 2022-10-05, latest 2026-09-17 18:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| CHILDS JOHN W | Dir | $25.00M | — |
| Coric Vlad | CEO, Dir | $5.00M | — |
| Bailey Gregory | Dir | $3.00M | — |
| Clark George C. | VP, CAO | $144.8K | — |
| Buten Matthew | CFO | — | — |
| Mehta Kishan | Dir | — | — |
| Car Bruce | CSO | — | — |
| Gentile Kimberly | SVP, Clinical Ops | — | — |
Transactions 106
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-17 | BHVN | Mehta Kishan | Dir | G - Gift | $0.00 | -17.3K | 5,320 | -77% | $0 | |
| I | 2026-03-19 | 2026-03-17 | BHVN | Mehta Kishan | Dir | G - Gift | $0.00 | +17.3K | 17.3K | New | $0 |
| AI | 2026-03-09 | 2025-03-04 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $30.43 | +28.4K | 2.32M | +1% | +$864.2K |
| D | 2026-01-07 | 2026-01-05 | BHVN | Coric Vlad | CEO, Dir | F - Tax | $9.93 | -7,430 | 1.80M | -0.4% | -$73.8K |
| D | 2026-01-07 | 2026-01-05 | BHVN | Coric Vlad | CEO, Dir | M - OptEx | $0.00 | +14.2K | 1.81M | +0.8% | $0 |
| D | 2026-01-07 | 2026-01-05 | BHVN | Car Bruce | CSO | F - Tax | $9.93 | -2,381 | 7,715 | -24% | -$23.6K |
| D | 2026-01-07 | 2026-01-05 | BHVN | Car Bruce | CSO | M - OptEx | $0.00 | +4,750 | 10.1K | +89% | $0 |
| D | 2026-01-07 | 2026-01-05 | BHVN | Gentile Kimberly | SVP, Clinical Ops | F - Tax | $9.93 | -1,956 | 99.6K | -2% | -$19.4K |
| D | 2026-01-07 | 2026-01-05 | BHVN | Gentile Kimberly | SVP, Clinical Ops | M - OptEx | $0.00 | +3,750 | 101.5K | +4% | $0 |
| D | 2026-01-07 | 2026-01-05 | BHVN | Buten Matthew | CFO | F - Tax | $9.93 | -2,594 | 195.7K | -1% | -$25.8K |
| D | 2026-01-07 | 2026-01-05 | BHVN | Buten Matthew | CFO | M - OptEx | $0.00 | +4,250 | 198.2K | +2% | $0 |
| D | 2026-01-07 | 2026-01-05 | BHVN | Clark George C. | VP, CAO | M - OptEx | $0.00 | +2,500 | 68.1K | +4% | $0 |
| D | 2026-01-07 | 2026-01-05 | BHVN | Clark George C. | VP, CAO | F - Tax | $9.93 | -1,117 | 67.0K | -2% | -$11.1K |
| I | 2025-11-18 | 2025-11-17 | BHVN | Clark George C. | VP, CAO | P - Purchase | $8.52 | +17.0K | 20.0K | +567% | +$144.8K |
| 2025-11-17 | 2025-11-13 | BHVN | Bailey Gregory | Dir | P - Purchase | $7.50 | +400.0K | 2.02M | +25% | +$3.00M | |
| I | 2025-11-17 | 2025-11-13 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $7.50 | +3.33M | 5.65M | +144% | +$25.00M |
| MI | 2025-11-17 | 2025-11-13 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $7.50 | +666.7K | 1.20M | +126% | +$5.00M |
| AI | 2025-03-05 | 2024-04-22 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $41.00 | +73.2K | 73.2K | New | +$3.00M |
| MI | 2025-03-05 | 2025-03-04 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $30.47 | +32.7K | 2.32M | +1% | +$996.4K |
| D | 2025-01-07 | 2025-01-05 | BHVN | Gentile Kimberly | SVP, Clinical Ops | F - Tax | $38.64 | -1,956 | 97.8K | -2% | -$75.6K |
| D | 2025-01-07 | 2025-01-05 | BHVN | Gentile Kimberly | SVP, Clinical Ops | M - OptEx | $0.00 | +3,750 | 99.7K | +4% | $0 |
| D | 2025-01-07 | 2025-01-05 | BHVN | Buten Matthew | CFO | F - Tax | $38.64 | -2,561 | 193.5K | -1% | -$99.0K |
| D | 2025-01-07 | 2025-01-05 | BHVN | Buten Matthew | CFO | M - OptEx | $0.00 | +4,250 | 196.0K | +2% | $0 |
| D | 2025-01-07 | 2025-01-05 | BHVN | Car Bruce | CSO | F - Tax | $38.64 | -2,331 | 4,802 | -33% | -$90.1K |
| D | 2025-01-07 | 2025-01-05 | BHVN | Car Bruce | CSO | M - OptEx | $0.00 | +4,750 | 7,133 | +199% | $0 |
| D | 2025-01-07 | 2025-01-05 | BHVN | Clark George C. | VP, CAO | F - Tax | $38.64 | -1,117 | 65.1K | -2% | -$43.2K |
| D | 2025-01-07 | 2025-01-05 | BHVN | Clark George C. | VP, CAO | M - OptEx | $0.00 | +2,500 | 66.2K | +4% | $0 |
| D | 2025-01-07 | 2025-01-05 | BHVN | Coric Vlad | CEO, Dir | F - Tax | $38.64 | -6,805 | 1.80M | -0.4% | -$262.9K |
| D | 2025-01-07 | 2025-01-05 | BHVN | Coric Vlad | CEO, Dir | M - OptEx | $0.00 | +14.2K | 1.80M | +0.8% | $0 |
| I | 2024-12-31 | 2024-12-30 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $35.94 | +29.0K | 2.37M | +1% | +$1.04M |
| I | 2024-10-03 | 2024-10-02 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $47.50 | +21.1K | 861.9K | +3% | +$1000.0K |
| I | 2024-10-03 | 2024-10-02 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $47.50 | +21.1K | 21.1K | New | +$1000.0K |
| 2024-09-25 | 2024-09-24 | BHVN | Bailey Gregory | Dir | P - Purchase | $44.19 | +5,000 | 1.62M | +0.3% | +$220.9K | |
| I | 2024-07-19 | 2024-07-18 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $35.67 | +28.4K | 2.34M | +1% | +$1.01M |
| I | 2024-06-20 | 2024-06-17 | BHVN | Car Bruce | CSO | P - Purchase | $33.58 | +30.0K | 30.0K | New | +$1.01M |
| I | 2024-05-31 | 2024-05-30 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $35.58 | +28.0K | 2.31M | +1% | +$996.2K |
| 2024-05-15 | 2024-05-13 | BHVN | Bailey Gregory | Dir | P - Purchase | $34.19 | +15.0K | 1.62M | +0.9% | +$512.8K | |
| I | 2024-05-14 | 2024-05-13 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $35.17 | +28.5K | 2.28M | +1% | +$1.00M |
| 2024-04-25 | 2024-04-24 | BHVN | Bailey Gregory | Dir | P - Purchase | $39.18 | +25.5K | 1.60M | +2% | +$999.2K | |
| 2024-04-23 | 2024-04-22 | BHVN | Bailey Gregory | Dir | P - Purchase | $41.00 | +48.8K | 1.57M | +3% | +$2.00M | |
| MI | 2024-04-23 | 2024-04-22 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $41.00 | +195.1K | 24.4K | New | +$8.00M |
| 2024-04-23 | 2024-04-22 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $41.00 | +122.0K | 1.79M | +7% | +$5.00M | |
| I | 2024-04-05 | 2024-04-05 | BHVN | CHILDS JOHN W | Dir | A - Grant | — | +2,091 | 2.18M | +0.1% | — |
| MI | 2024-04-05 | 2024-04-05 | BHVN | Coric Vlad | CEO, Dir | A - Grant | — | +462 | 840.9K | +0.1% | — |
| 2024-04-05 | 2024-04-05 | BHVN | Coric Vlad | CEO, Dir | A - Grant | — | +232 | 1.67M | +0.0% | — | |
| I | 2024-03-08 | 2024-03-08 | BHVN | CHILDS JOHN W | Dir | A - Grant | — | +19.4K | 2.18M | +0.9% | — |
| 2024-03-08 | 2024-03-08 | BHVN | Coric Vlad | CEO, Dir | A - Grant | — | +2,162 | 1.67M | +0.1% | — | |
| MI | 2024-03-08 | 2024-03-08 | BHVN | Coric Vlad | CEO, Dir | A - Grant | — | +4,310 | 840.7K | +0.5% | — |
| 2024-01-10 | 2024-01-08 | BHVN | Coric Vlad | CEO, Dir | A - Grant | — | +5,400 | 1.66M | +0.3% | — | |
| MI | 2024-01-10 | 2024-01-08 | BHVN | Coric Vlad | CEO, Dir | A - Grant | — | +10.8K | 404.8K | +3% | — |
| I | 2024-01-10 | 2024-01-08 | BHVN | CHILDS JOHN W | Dir | J - Other | — | +48.5K | 2.16M | +2% | — |
| D | 2023-12-29 | 2023-12-29 | BHVN | Antonijevic Irina | Dir | M - OptEx | $0.00 | +11.0K | 13.5K | +434% | $0 |
| D | 2023-12-29 | 2023-12-29 | BHVN | Antonijevic Irina | Dir | S - Sale+OE | $41.79 | -11.0K | 2,535 | -81% | -$459.7K |
| I | 2023-10-10 | 2023-10-05 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $22.00 | +340.9K | 833.1K | +69% | +$7.50M |
| 2023-10-10 | 2023-10-05 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $22.00 | +113.6K | 1.66M | +7% | +$2.50M | |
| MI | 2023-10-10 | 2023-10-05 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $22.00 | +454.5K | 2.11M | +27% | +$10.00M |
| 2023-10-06 | 2023-10-05 | BHVN | Buten Matthew | CFO | P - Purchase | $22.00 | +22.7K | 189.4K | +14% | +$500.0K | |
| 2023-10-06 | 2023-10-04 | BHVN | Bailey Gregory | Dir | P - Purchase | $22.57 | +17.8K | 1.53M | +1% | +$402.1K | |
| I | 2023-08-31 | 2023-08-30 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $18.44 | +50.0K | 1.98M | +3% | +$922.0K |
| I | 2023-08-07 | 2023-08-04 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $19.78 | +100.0K | 1.93M | +5% | +$1.98M |
| MAI | 2023-03-22 | 2022-10-25 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $10.50 | +3.71M | 1.83M | New | +$38.95M |
| 2022-11-01 | 2022-10-31 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $15.97 | +25.8K | 1.54M | +2% | +$412.0K | |
| 2022-10-31 | 2022-10-28 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $14.87 | +41.9K | 1.52M | +3% | +$623.5K | |
| I | 2022-10-31 | 2022-10-28 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $14.82 | +100.0K | 109.6K | +1,045% | +$1.48M |
| 2022-10-26 | 2022-10-25 | BHVN | GREGORY JULIA P | Dir | P - Purchase | $10.50 | +9,523 | 25.7K | +59% | +$100.0K | |
| 2022-10-26 | 2022-10-25 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $10.50 | +3.90M | 5.69M | +218% | +$40.95M | |
| 2022-10-26 | 2022-10-25 | BHVN | Buten Matthew | CFO | P - Purchase | $10.50 | +142.9K | 166.7K | +600% | +$1.50M | |
| 2022-10-26 | 2022-10-25 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $10.50 | +853.4K | 1.48M | +137% | +$8.96M | |
| 2022-10-26 | 2022-10-25 | BHVN | Bailey Gregory | Dir | P - Purchase | $10.50 | +200.0K | 1.51M | +15% | +$2.10M | |
| A | 2022-10-12 | 2022-10-03 | BHVN | Coric Vlad | CEO, Dir | J - Other | — | 0 | 569.3K | New | — |
| A | 2022-10-12 | 2022-10-03 | BHVN | HUGIN ROBERT J | Dir | F - Tax | $7.50 | -13.0K | 13.0K | -50% | -$97.2K |
| A | 2022-10-12 | 2022-10-03 | BHVN | Heffernan Michael Thomas | Dir | F - Tax | $7.50 | -9,699 | 15.2K | -39% | -$72.7K |
| MI | 2022-10-06 | 2022-10-05 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $10.31 | +485.8K | 399.4K | New | +$5.01M |
| DM | 2022-10-05 | 2022-10-03 | BHVN | HUGIN ROBERT J | Dir | J - Other | $0.00 | +3,158 | 1,450 | New | $0 |
| D | 2022-10-05 | 2022-10-03 | BHVN | HUGIN ROBERT J | Dir | F - Tax | $7.50 | -3,263 | 19.5K | -14% | -$24.5K |
| DM | 2022-10-05 | 2022-10-03 | BHVN | HUGIN ROBERT J | Dir | M - OptEx | $3.75 | +19.6K | 7,277 | New | +$73.4K |
| D | 2022-10-05 | 2022-10-03 | BHVN | Antonijevic Irina | Dir | J - Other | $0.00 | +2,535 | 2,535 | New | $0 |
| DM | 2022-10-05 | 2022-10-03 | BHVN | CHILDS JOHN W | Dir | M - OptEx | $4.08 | +10.1K | 1.53M | +0.7% | +$41.3K |
| D | 2022-10-05 | 2022-10-03 | BHVN | CHILDS JOHN W | Dir | F - Tax | $7.50 | -5,507 | 1.52M | -0.4% | -$41.3K |
| D | 2022-10-05 | 2022-10-03 | BHVN | CHILDS JOHN W | Dir | J - Other | $0.00 | +1.52M | 1.52M | New | $0 |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Coric Vlad | CEO, Dir | M - OptEx | $1.48 | +586.2K | 696.2K | +533% | +$869.5K |
| D | 2022-10-05 | 2022-10-03 | BHVN | Coric Vlad | CEO, Dir | F - Tax | $7.50 | -115.9K | 1.04M | -10% | -$869.5K |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Coric Vlad | CEO, Dir | J - Other | $0.00 | +567.4K | 567.4K | New | $0 |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Buten Matthew | CFO | J - Other | $0.00 | +21.8K | 21.8K | New | $0 |
| D | 2022-10-05 | 2022-10-03 | BHVN | Buten Matthew | CFO | F - Tax | $7.50 | -11.0K | 23.8K | -32% | -$82.8K |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Buten Matthew | CFO | M - OptEx | $6.37 | +13.0K | 23.4K | +125% | +$82.8K |
| DM | 2022-10-05 | 2022-10-03 | BHVN | GREGORY JULIA P | Dir | M - OptEx | $3.19 | +28.1K | 19.1K | New | +$89.8K |
| D | 2022-10-05 | 2022-10-03 | BHVN | GREGORY JULIA P | Dir | F - Tax | $7.50 | -12.0K | 16.1K | -43% | -$89.8K |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Heffernan Michael Thomas | Dir | M - OptEx | $3.13 | +23.2K | 24.9K | +1,399% | +$72.7K |
| D | 2022-10-05 | 2022-10-03 | BHVN | Heffernan Michael Thomas | Dir | F - Tax | $7.50 | -5,507 | 19.4K | -22% | -$41.3K |
| D | 2022-10-05 | 2022-10-03 | BHVN | Heffernan Michael Thomas | Dir | J - Other | $0.00 | +1,660 | 1,660 | New | $0 |
| MAI | 2022-10-05 | 2022-10-03 | BHVN | Coric Vlad | CEO, Dir | J - Other | $0.00 | +415.4K | 9,565 | New | $0 |
| A | 2022-10-05 | 2022-10-03 | BHVN | Coric Vlad | CEO, Dir | J - Other | $0.00 | +46.0K | 622.3K | +8% | $0 |
| A | 2022-10-05 | 2022-10-03 | BHVN | CHILDS JOHN W | Dir | J - Other | $0.00 | +1.51M | 1.52M | +32,809% | $0 |
| AI | 2022-10-05 | 2022-10-03 | BHVN | CHILDS JOHN W | Dir | J - Other | $0.00 | +5,000 | 5,000 | New | $0 |
| M | 2022-10-05 | 2022-10-05 | BHVN | CHILDS JOHN W | Dir | P - Purchase | $8.98 | +274.1K | 1.79M | +18% | +$2.46M |
| M | 2022-10-05 | 2022-10-03 | BHVN | Biohaven Pharmaceutical Holding Co Ltd. | 10% | J - Other | $0.00 | 0 | 35.84M | New | $0 |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Gentile Kimberly | SVP, Clinical Ops | M - OptEx | $2.43 | +115.5K | 116.5K | +12,146% | +$281.2K |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Gentile Kimberly | SVP, Clinical Ops | J - Other | $0.00 | +18.0K | 5,826 | New | $0 |
| D | 2022-10-05 | 2022-10-03 | BHVN | Gentile Kimberly | SVP, Clinical Ops | F - Tax | $7.00 | -37.5K | 96.0K | -28% | -$262.4K |
Purchase Sale Sale after option exercise All abbreviations